Visit COVID-19 resources

[Skip to Content]

diabetic macular oedema

Intravitreal-Injection-Therapy-August-2018-2

Aug 28
2018

Ophthalmic Service Guidance on intravitreal injections

  • 28 August 2018

Fluocinolone acetonide intravitreal implant for treating chronic DMO after inadequate response to prior therapy

Dec 30
2014

College statement on NICE guidance TA 301 – Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after inadequate response to prior therapy (rapid review of technology appraisal guidance 271) December 2013

  • 30 December 2014